FDA Rushed Out Agency-Wide AI Tool—It’s Not Going Well

FDA claims victory with "Elsa" AI tool launch, but insiders call it half-baked

The Food and Drug Administration has officially launched "Elsa," a generative artificial intelligence platform designed to help staff across the agency work more efficiently. However, internal critics argue the rollout moved too quickly and say the tool, in its current state, is underwhelming.Read Entire Article

Scientists argue for more FDA oversight of health care AI tools

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical technologies. That is the takeaway from a new report issued to the FDA, published this week in the open-access journal PLOS Digital Health by Leo Celi of the Massachusetts Institute of Technology and colleagues.

FDA rushed out agency-wide AI tool—it’s not going well

An agency-wide LLM called Elsa was released weeks ahead of schedule.

FDA’s Elsa AI is here, and the industry has questions

The agency has provided few details about its AI pilot as it makes moves on its “aggressive timeline” for rollout.

Turns out crappy AI cannot actually replace government workers

Not one but two artificial intelligence tools have been rolled out at the Food and Drug Administration. And, unsurprisingly, not one but two of them appear to suck.� FDA Commissioner Martin Makary ...

FDA's AI tool, Elsa, is here. 'The stupidest big fuss they ever made'

In this edition of STAT's AI Prognosis: FDA's AI tool, Elsa was launched across the agency weeks ahead of shcedule, and more health AI news.